Cargando…
Identification of potential edible mushroom as SARS-CoV-2 main protease inhibitor using rational drug designing approach
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is highly pathogenic to humans and has created health care threats worldwide. This urgent situation has focused the researchers worldwide towards the development of novel vaccine or small molecule therapeutics for SARS-CoV-2. Although seve...
Autores principales: | Sen, Debanjan, Debnath, Bimal, Debnath, Pradip, Debnath, Sudhan, Zaki, Magdi E. A., Masand, Vijay H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8795408/ https://www.ncbi.nlm.nih.gov/pubmed/35087077 http://dx.doi.org/10.1038/s41598-022-05349-x |
Ejemplares similares
-
Three-dimensional quantitative structure-activity relationships and docking studies of some structurally diverse flavonoids and design of new aldose reductase inhibitors
por: Chandra De, Utpal, et al.
Publicado: (2015) -
Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor
por: Suryavanshi, Hemant, et al.
Publicado: (2022) -
Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database
por: Sarkar, Arkadeep, et al.
Publicado: (2021) -
Bis-indolylation of aldehydes and ketones using silica-supported FeCl(3): molecular docking studies of bisindoles by targeting SARS-CoV-2 main protease binding sites
por: Deb, Barnali, et al.
Publicado: (2021) -
Identification of Food Compounds as inhibitors of SARS-CoV-2 main protease using molecular docking and molecular dynamics simulations
por: Masand, Vijay H., et al.
Publicado: (2021)